Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles
Display Omitted
Gespeichert in:
| Autor*in: |
Wang, Wei-Yuan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
12 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:515 ; year:2016 ; number:1 ; day:30 ; month:12 ; pages:221-232 ; extent:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2016.10.022 |
|---|
| Katalog-ID: |
ELV019422032 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019422032 | ||
| 003 | DE-627 | ||
| 005 | 20230623151020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2016.10.022 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000048A.pica |
| 035 | |a (DE-627)ELV019422032 | ||
| 035 | |a (ELSEVIER)S0378-5173(16)30956-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Wang, Wei-Yuan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles |
| 264 | 1 | |c 2016 | |
| 300 | |a 12 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Discrete nanoparticles |2 Elsevier | |
| 650 | 7 | |a Gold |2 Elsevier | |
| 650 | 7 | |a Anticancer drug |2 Elsevier | |
| 650 | 7 | |a Methotrexate |2 Elsevier | |
| 650 | 7 | |a Nanochains |2 Elsevier | |
| 700 | 1 | |a Zhao, Xiu-Fen |4 oth | |
| 700 | 1 | |a Ju, Xiao-Han |4 oth | |
| 700 | 1 | |a Wang, Yu |4 oth | |
| 700 | 1 | |a Wang, Lin |4 oth | |
| 700 | 1 | |a Li, Shu-Ping |4 oth | |
| 700 | 1 | |a Li, Xiao-Dong |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:515 |g year:2016 |g number:1 |g day:30 |g month:12 |g pages:221-232 |g extent:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2016.10.022 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 515 |j 2016 |e 1 |b 30 |c 1230 |h 221-232 |g 12 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
w y w wyw |
|---|---|
| matchkey_str |
wangweiyuanzhaoxiufenjuxiaohanwangyuwang:2016----:oemrhlgcagoamtorxtcnuaefonncant |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.61 |
| publishDate |
2016 |
| allfields |
10.1016/j.ijpharm.2016.10.022 doi GBV00000000000048A.pica (DE-627)ELV019422032 (ELSEVIER)S0378-5173(16)30956-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Wang, Wei-Yuan verfasserin aut Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles 2016 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Elsevier Zhao, Xiu-Fen oth Ju, Xiao-Han oth Wang, Yu oth Wang, Lin oth Li, Shu-Ping oth Li, Xiao-Dong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 https://doi.org/10.1016/j.ijpharm.2016.10.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 515 2016 1 30 1230 221-232 12 045F 610 |
| spelling |
10.1016/j.ijpharm.2016.10.022 doi GBV00000000000048A.pica (DE-627)ELV019422032 (ELSEVIER)S0378-5173(16)30956-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Wang, Wei-Yuan verfasserin aut Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles 2016 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Elsevier Zhao, Xiu-Fen oth Ju, Xiao-Han oth Wang, Yu oth Wang, Lin oth Li, Shu-Ping oth Li, Xiao-Dong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 https://doi.org/10.1016/j.ijpharm.2016.10.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 515 2016 1 30 1230 221-232 12 045F 610 |
| allfields_unstemmed |
10.1016/j.ijpharm.2016.10.022 doi GBV00000000000048A.pica (DE-627)ELV019422032 (ELSEVIER)S0378-5173(16)30956-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Wang, Wei-Yuan verfasserin aut Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles 2016 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Elsevier Zhao, Xiu-Fen oth Ju, Xiao-Han oth Wang, Yu oth Wang, Lin oth Li, Shu-Ping oth Li, Xiao-Dong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 https://doi.org/10.1016/j.ijpharm.2016.10.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 515 2016 1 30 1230 221-232 12 045F 610 |
| allfieldsGer |
10.1016/j.ijpharm.2016.10.022 doi GBV00000000000048A.pica (DE-627)ELV019422032 (ELSEVIER)S0378-5173(16)30956-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Wang, Wei-Yuan verfasserin aut Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles 2016 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Elsevier Zhao, Xiu-Fen oth Ju, Xiao-Han oth Wang, Yu oth Wang, Lin oth Li, Shu-Ping oth Li, Xiao-Dong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 https://doi.org/10.1016/j.ijpharm.2016.10.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 515 2016 1 30 1230 221-232 12 045F 610 |
| allfieldsSound |
10.1016/j.ijpharm.2016.10.022 doi GBV00000000000048A.pica (DE-627)ELV019422032 (ELSEVIER)S0378-5173(16)30956-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Wang, Wei-Yuan verfasserin aut Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles 2016 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Elsevier Zhao, Xiu-Fen oth Ju, Xiao-Han oth Wang, Yu oth Wang, Lin oth Li, Shu-Ping oth Li, Xiao-Dong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 https://doi.org/10.1016/j.ijpharm.2016.10.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 515 2016 1 30 1230 221-232 12 045F 610 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:515 year:2016 number:1 day:30 month:12 pages:221-232 extent:12 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Discrete nanoparticles Gold Anticancer drug Methotrexate Nanochains |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Wang, Wei-Yuan @@aut@@ Zhao, Xiu-Fen @@oth@@ Ju, Xiao-Han @@oth@@ Wang, Yu @@oth@@ Wang, Lin @@oth@@ Li, Shu-Ping @@oth@@ Li, Xiao-Dong @@oth@@ |
| publishDateDaySort_date |
2016-01-30T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV019422032 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019422032</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623151020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2016.10.022</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000048A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019422032</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(16)30956-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wang, Wei-Yuan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Discrete nanoparticles</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gold</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anticancer drug</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Methotrexate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanochains</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xiu-Fen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ju, Xiao-Han</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Yu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Lin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Shu-Ping</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Xiao-Dong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:515</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">day:30</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:221-232</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2016.10.022</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">515</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="b">30</subfield><subfield code="c">1230</subfield><subfield code="h">221-232</subfield><subfield code="g">12</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Wang, Wei-Yuan |
| spellingShingle |
Wang, Wei-Yuan ddc 610 bkl 44.61 Elsevier Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles |
| authorStr |
Wang, Wei-Yuan |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.61 bkl Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Discrete nanoparticles Elsevier Gold Elsevier Anticancer drug Elsevier Methotrexate Elsevier Nanochains |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
x f z xfz x h j xhj y w yw l w lw s p l spl x d l xdl |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles |
| ctrlnum |
(DE-627)ELV019422032 (ELSEVIER)S0378-5173(16)30956-5 |
| title_full |
Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles |
| author_sort |
Wang, Wei-Yuan |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
221 |
| author_browse |
Wang, Wei-Yuan |
| container_volume |
515 |
| physical |
12 |
| class |
610 610 DE-600 610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Wang, Wei-Yuan |
| doi_str_mv |
10.1016/j.ijpharm.2016.10.022 |
| dewey-full |
610 |
| title_sort |
novel morphology change of au-methotrexate conjugates: from nanochains to discrete nanoparticles |
| title_auth |
Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
1 |
| title_short |
Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles |
| url |
https://doi.org/10.1016/j.ijpharm.2016.10.022 |
| remote_bool |
true |
| author2 |
Zhao, Xiu-Fen Ju, Xiao-Han Wang, Yu Wang, Lin Li, Shu-Ping Li, Xiao-Dong |
| author2Str |
Zhao, Xiu-Fen Ju, Xiao-Han Wang, Yu Wang, Lin Li, Shu-Ping Li, Xiao-Dong |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijpharm.2016.10.022 |
| up_date |
2024-07-06T21:24:45.332Z |
| _version_ |
1803866430854135808 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019422032</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623151020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2016.10.022</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000048A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019422032</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(16)30956-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wang, Wei-Yuan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Discrete nanoparticles</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gold</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anticancer drug</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Methotrexate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanochains</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xiu-Fen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ju, Xiao-Han</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Yu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Lin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Shu-Ping</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Xiao-Dong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:515</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">day:30</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:221-232</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2016.10.022</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">515</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="b">30</subfield><subfield code="c">1230</subfield><subfield code="h">221-232</subfield><subfield code="g">12</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.402237 |